Structural Genomics Consortium funding announced

Guest Contributor
July 23, 2007

Complete funding for the second phase of the Structural Genomics Consortium has been announced, with 13 partners (including three pharmaceutical firms) providing more than $105 million. The consortium — led by Dr Aled Edwards at the Univ of Toronto with three nodes in Toronto, the Univ of Oxford and the Karolinska Institutet — is dedicated to identifying protein structures related to human disease and making them freely available for research. The Ontario Ministry of Research and Innovation (MRI) has already announced its $15-million contribution (R$, April 10/07). The other funding partners and their contributions (where available) are: The Wellcome Trust ($34.2 million), Genome Canada through the Ontario Genomics Institute) ($18 million, Canadian Institutes of Health Research ($10 million), Canada Foundation for Innovation ($3.2 million) and four Swedish organizations. They are the Karolinska Institutet , Swedish Foundation for Strategic Research, VINNOVA (a Swedish government agency for innovation systems) and Knut and Alice Wallenberg Foundation. The amounts of their contributions and those of the three pharmaceutical firms — Novartis, Merck & Co and GlaxoSmithKline plc — have not been released….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.